Navigation Links
CMS Selects Thomson Reuters to Help Implement Medicare Medical Home Demonstration Project for Medicare Recipients

ANN ARBOR, Mich., Jan. 28 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has engaged the Healthcare business of Thomson Reuters in a 4-1/2 year contract to manage the implementation of the Medicare Medical Home Demonstration.

This project involves physician-based office practices delivering Medical Home services to Medicare fee-for-service beneficiaries. Medical Home practices are specially qualified to provide patient-centered, comprehensive and continuous patient care through a personal physician and the practice team.

The demonstration will be conducted in up to eight states and will involve about 400 medical practices, 2,000 physicians, and 400,000 Medicare beneficiaries. Participating practices will provide Medical Home services to patients from January 2010 through December 2012 and receive additional monthly care management fees from CMS.

Thomson Reuters will be responsible for recruiting and qualifying physician practices to participate in the demonstration, and for monitoring beneficiary enrollment and participation. The National Committee for Quality Assurance (NCQA), under contract to Thomson Reuters, will conduct the practice application and qualification processes to certify that participating practices have core Medical Home capabilities.

Throughout 2009, Thomson Reuters will contact medical practices in the demonstration areas and, via a web site and other outreach efforts, provide physicians with information about participating in the program.

Beginning in 2010, Thomson Reuters also will facilitate a two-year beneficiary enrollment period. Beneficiaries with Medicare fee-for-service coverage who live within the demonstration locations may voluntarily participate if they have at least one qualifying chronic disease. For the duration of the project, Thomson Reuters will monitor patients' eligibility for the demonstration and visits to their Medical Home.

Information about the Medicare Medical Home Demonstration is available on the project website at

About Thomson Reuters

The Healthcare business of Thomson Reuters produces insights, information, benchmarks and analysis that enable organizations to manage costs, improve performance and enhance the quality of healthcare. Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. Thomson Reuters shares are listed on the New York Stock Exchange (NYSE: TRI); Toronto Stock Exchange (TSX: TRI); London Stock Exchange (LSE: TRIL); and Nasdaq (Nasdaq: TRIN). For more information, go to

SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
2. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
3. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
4. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
5. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
6. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
7. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
8. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
9. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
10. Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal
11. Fallon Community Health Plan Selects CaseNET to Enhance Care Services Infrastructure
Post Your Comments:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: